We are live on ! Find out more
AC

Allstate Corporation Portfolio holdings

AUM $10B
1-Year Est. Return 30.74%
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+30.74%
3 Year Est. Return
+59.66%
5 Year Est. Return
+58.64%
10 Year Est. Return
+179.39%
AUM
$10B
AUM Growth
+$662M
Cap. Flow
-$404M
Cap. Flow %
-4.03%
Top 10 Hldgs %
41.43%
Holding
1,451
New
327
Increased
520
Reduced
475
Closed
113
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CORT icon
1251
Corcept Therapeutics
CORT
$12.2B
$252K ﹤0.01%
+2,896
New +$175K
ORRF icon
1252
Orrstown Financial Services
ORRF
$835M
$250K ﹤0.01%
+6,119
New +$231K
VCYT icon
1253
Veracyte
VCYT
$3.59B
$250K ﹤0.01%
+4,250
New +$178K
ACVA icon
1254
ACV Auctions
ACVA
$1.14B
$249K ﹤0.01%
+34,570
New +$196K
ARRY icon
1255
Array Technologies
ARRY
$699M
$248K ﹤0.01%
33,478
+65
+0.2% +$518
EFOR
1256
Everforth Inc
EFOR
$1.31B
$247K ﹤0.01%
+13,836
New +$338K
EOSE icon
1257
Eos Energy Enterprises
EOSE
$1.27B
$247K ﹤0.01%
41,962
+49
+0.1% +$341
CMP icon
1258
Compass Minerals
CMP
$1.06B
$246K ﹤0.01%
+7,915
New +$224K
NCLH icon
1259
Norwegian Cruise Line
NCLH
$7.16B
$242K ﹤0.01%
11,468
-54,169
-83% -$1.01M
PLAY icon
1260
Dave & Buster's
PLAY
$302M
$241K ﹤0.01%
21,106
+6,035
+40% +$71.9K
TRMB icon
1261
Trimble
TRMB
$14B
$239K ﹤0.01%
4,678
-25,759
-85% -$1.52M
GLIBK
1262
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.04B
$237K ﹤0.01%
+10,992
New +$309K
SPRY icon
1263
ARS Pharmaceuticals
SPRY
$564M
$237K ﹤0.01%
+29,551
New +$254K
ARQT icon
1264
Arcutis Biotherapeutics
ARQT
$2.97B
$236K ﹤0.01%
+8,996
New +$210K
REZI icon
1265
Resideo Technologies
REZI
$2.97B
$236K ﹤0.01%
+7,580
New +$261K
AEO icon
1266
American Eagle Outfitters
AEO
$2.85B
$235K ﹤0.01%
+13,680
New +$237K
SCL icon
1267
Stepan Co
SCL
$1.42B
$235K ﹤0.01%
+4,219
New +$219K
SNDR icon
1268
Schneider National
SNDR
$5.97B
$234K ﹤0.01%
+6,399
New +$209K
MDU icon
1269
MDU Resources
MDU
$4.15B
$232K ﹤0.01%
+10,953
New +$238K
MKSI icon
1270
MKS Inc
MKSI
$16.9B
$232K ﹤0.01%
521
-8,749
-94% -$2.74M
APPN icon
1271
Appian
APPN
$2.92B
$231K ﹤0.01%
+10,087
New +$224K
CSTL icon
1272
Castle Biosciences
CSTL
$997M
$230K ﹤0.01%
+9,642
New +$215K
AMPH icon
1273
Amphastar Pharmaceuticals
AMPH
$1.01B
$229K ﹤0.01%
+11,353
New +$229K
CARG icon
1274
CarGurus
CARG
$3.05B
$229K ﹤0.01%
6,708
-11,537
-63% -$374K
BHVN icon
1275
Biohaven
BHVN
$2.4B
$229K ﹤0.01%
+15,360
New +$165K

Similar funds

Allstate Corporation's Q2 2026 Portfolio in Review

As of Q2 2026, Allstate Corporation held 1,451 positions worth $10B, up 7.1% from $9.35B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Allstate Corporation withdrew a net $404M in Q2 2026, closing 113 positions and reducing 475 holdings. Its most notable exit was iShares Russell 1000 ETF, an estimated $197M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 37% a quarter earlier, followed by Technology and Financials.

Against the trend, Allstate Corporation opened a new position in Schwab 5-10 Year Corporate Bond ETF worth $41.7M.

  • Allstate Corporation's largest Q2 2026 buy was Schwab 5-10 Year Corporate Bond ETF: 1,839,862 shares worth $41.7M.
  • Allstate Corporation added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2026, an estimated $220M increase.
  • Allstate Corporation's biggest Q2 2026 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $108M.
  • Allstate Corporation fully exited iShares Russell 1000 ETF in Q2 2026, selling an estimated $197M.
  • Allstate Corporation's ten largest holdings make up 41% of its $10B portfolio in Q2 2026.
  • Allstate Corporation opened 327 new positions and closed 113 in Q2 2026.
  • Allstate Corporation's portfolio value rose 7.1% quarter-over-quarter to $10B.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.